Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T18:27:30.057Z.
Calculation as of: 2026-10-06T18:27:30.057Z.
Quote observation: 2026-10-06T18:25:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 55b8dbabd3995de6814355fb2a21bc992d842325745fe4a48a34f8d646fc1b47
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-05-06.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
PRICE/FCF RATIO AVG TTM
N/A
PRICE/FCF RATIO AVG 3Y
N/A
PRICE/FCF RATIO AVG 5Y
N/A
PRICE/FCF RATIO AVG 10Y
N/A
PRICE/FCF RATIO AVG 15Y
N/A
PRICE/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Mirum Pharmaceuticals, Inc.
Market Cap
$4.80B
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.71B
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.71B
Price/FCF Ratio
142.04
TTM Avg
194.41
3Y Avg
194.41
5Y Avg
194.41
Market Cap
$4.68B
Price/FCF Ratio
26.92
TTM Avg
23.99
3Y Avg
32.53
5Y Avg
32.53
Market Cap
$4.68B
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.65B
Price/FCF Ratio
N/A
TTM Avg
17.05
3Y Avg
20.25
5Y Avg
24.33
Market Cap
$5.04B
Price/FCF Ratio
20.46
TTM Avg
18.20
3Y Avg
218.90
5Y Avg
218.90
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | $4.80B | N/A | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.81B | N/A | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.71B | N/A | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.71B | 142.04 | 194.41 | 194.41 | 194.41 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 26.92 | 23.99 | 32.53 | 32.53 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.68B | N/A | N/A | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | N/A | 17.05 | 20.25 | 24.33 |
| Erasca, Inc. (ERAS)vs › | $4.98B | N/A | N/A | N/A | N/A |
| Waystar Holding Corp. (WAY)vs › | $5.04B | 20.46 | 18.20 | 218.90 | 218.90 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.06B | 24.85 | 26.02 | 39.55 | 43.37 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/FCF RATIO |
|---|---|
| 2026-05-06 | 100.70 |
| 2026-05-05 | 96.80 |
| 2026-05-04 | 96.78 |
| 2026-05-01 | 88.31 |
| 2026-04-30 | 89.02 |
| 2026-04-29 | 86.17 |
| 2026-04-28 | 85.99 |
| 2026-04-27 | 84.60 |
| 2026-04-24 | 83.70 |
| 2026-04-23 | 84.12 |
| 2026-04-22 | 86.28 |
| 2026-04-21 | 85.38 |
| 2026-04-20 | 87.56 |
| 2026-04-17 | 89.61 |
| 2026-04-16 | 87.69 |
| 2026-04-15 | 88.19 |
| 2026-04-14 | 88.64 |
| 2026-04-13 | 88.27 |
| 2026-04-10 | 87.09 |
| 2026-04-09 | 90.52 |
| 2026-04-08 | 89.61 |
| 2026-04-07 | 87.50 |
| 2026-04-06 | 88.04 |
| 2026-04-02 | 86.15 |
| 2026-04-01 | 86.56 |
| 2026-03-31 | 84.51 |
| 2026-03-30 | 80.41 |
| 2026-03-27 | 80.91 |
| 2026-03-26 | 81.31 |
| 2026-03-25 | 82.49 |
| 2026-03-24 | 80.39 |
| 2026-03-23 | 81.81 |
| 2026-03-20 | 80.97 |
| 2026-03-19 | 82.99 |
| 2026-03-18 | 83.85 |
| 2026-03-17 | 88.32 |
| 2026-03-16 | 84.75 |
| 2026-03-13 | 82.94 |
| 2026-03-12 | 82.13 |
| 2026-03-11 | 83.93 |
| 2026-03-10 | 83.18 |
| 2026-03-09 | 81.22 |
| 2026-03-06 | 78.95 |
| 2026-03-05 | 80.36 |
| 2026-03-04 | 85.11 |
| 2026-03-03 | 80.32 |
| 2026-03-02 | 82.42 |
| 2026-02-27 | 84.43 |
| 2026-02-26 | 84.34 |
| 2026-02-25 | 139.69 |
| 2026-02-24 | 138.22 |
| 2026-02-23 | 136.18 |
| 2026-02-20 | 135.24 |
| 2026-02-19 | 135.66 |
| 2026-02-18 | 135.16 |
| 2026-02-17 | 132.24 |
| 2026-02-13 | 132.59 |
| 2026-02-12 | 131.19 |
| 2026-02-11 | 128.45 |
| 2026-02-10 | 129.77 |
| 2026-02-09 | 129.30 |
| 2026-02-06 | 129.21 |
| 2026-02-05 | 126.33 |
| 2026-02-04 | 133.69 |
| 2026-02-03 | 135.61 |
| 2026-02-02 | 133.49 |
| 2026-01-30 | 132.74 |
| 2026-01-29 | 132.36 |
| 2026-01-28 | 129.70 |
| 2026-01-27 | 127.66 |
| 2026-01-26 | 124.64 |
| 2026-01-23 | 121.26 |
| 2026-01-22 | 123.50 |
| 2026-01-21 | 119.95 |
| 2026-01-20 | 118.17 |
| 2026-01-16 | 117.09 |
| 2026-01-15 | 118.73 |
| 2026-01-14 | 116.58 |
| 2026-01-13 | 116.31 |
| 2026-01-12 | 115.10 |
| 2026-01-09 | 111.33 |
| 2026-01-08 | 104.94 |
| 2026-01-07 | 105.43 |
| 2026-01-06 | 98.33 |
| 2026-01-05 | 97.17 |
| 2026-01-02 | 100.40 |
| 2025-12-31 | 101.58 |
| 2025-12-30 | 101.40 |
| 2025-12-29 | 103.15 |
| 2025-12-26 | 101.93 |
| 2025-12-24 | 103.85 |
| 2025-12-23 | 102.95 |
| 2025-12-22 | 104.26 |
| 2025-12-19 | 99.98 |
| 2025-12-18 | 90.38 |
| 2025-12-17 | 88.74 |
| 2025-12-16 | 86.23 |
| 2025-12-15 | 82.43 |
| 2025-12-12 | 83.59 |
| 2025-12-11 | 84.52 |
| 2025-12-10 | 83.17 |
| 2025-12-09 | 84.11 |
| 2025-12-08 | 87.32 |
| 2025-12-05 | 88.07 |
| 2025-12-04 | 91.99 |
| 2025-12-03 | 91.29 |
| 2025-12-02 | 89.87 |
| 2025-12-01 | 90.03 |
| 2025-11-28 | 93.94 |
| 2025-11-26 | 94.05 |
| 2025-11-25 | 92.28 |
| 2025-11-24 | 92.85 |
| 2025-11-21 | 91.27 |
| 2025-11-20 | 88.94 |
| 2025-11-19 | 90.59 |
| 2025-11-18 | 92.84 |
| 2025-11-17 | 92.86 |
| 2025-11-14 | 91.87 |
| 2025-11-13 | 89.06 |
| 2025-11-12 | 91.02 |
| 2025-11-11 | 91.72 |
| 2025-11-10 | 89.65 |
| 2025-11-07 | 87.59 |
| 2025-11-06 | 87.09 |
| 2025-11-05 | 90.14 |
